Dr. Doris Taylor is a world leader in cardiovascular regenerative medicine, known for creating the first personalized human heart using tissue engineering. A pioneer in cell and gene therapy, she has authored nearly 200 publications, holds 30+ patents, and founded multiple biotech companies. Her breakthroughs have been featured in Nature Medicine, JAMA, Circulation, and by global media, including 60 Minutes and BBC. A Fellow of the AHA and ACC, Dr. Taylor has held faculty roles at Duke, Texas Heart Institute, and more. She currently leads RegenMedix Consulting to accelerate innovation from bench to bedside.